Stock PBH PRESTIGE CONSUMER HEALTHCARE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Prestige Consumer Healthcare Inc.

Equities

PBH

US74112D1019

Pharmaceuticals

Market Closed - Nyse
Other stock markets
 01:30:01 27/04/2024 am IST 		5-day change 1st Jan Change
70.47 USD +0.47% Intraday chart for Prestige Consumer Healthcare Inc. +1.15% +15.11%
16/02 Prestige Consumer Healthcare Insider Sold Shares Worth $1,766,665, According to a Recent SEC Filing MT
16/02 Prestige Consumer Healthcare Insider Sold Shares Worth $2,051,874, According to a Recent SEC Filing MT

Business Summary

Prestige Consumer Healthcare Inc. is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club and e-commerce stores in North America (the United States and Canada) and in Australia and certain other international markets. The Company operates through two segments: North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands include Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart treatments, Little Remedies pediatric over-the-counter products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment, Debrox earwax remover, and others.

Number of employees: 560

Sales per Business

USD in Million2022Weight2023Weight Delta
North American Over-the-counter Healthcare
86.3 %
968 89.1 % 974 86.3 % +0.61%
International Over-the-counter Healthcare
13.7 %
119 10.9 % 154 13.7 % +29.45%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
84.5 %
910 83.7 % 953 84.5 % +4.74%
Rest of World
13.7 %
118 10.9 % 154 13.7 % +30.42%
North America
1.8 %
58 5.4 % 20 1.8 % -65.65%

Managers

Managers TitleAgeSince
Ronald Lombardi CEO
 Chief Executive Officer 60 06/10/06
Christine Sacco DFI
 Director of Finance/CFO 49 12/16/12
Jeff Zerillo COO
 Chief Operating Officer 63 01/18/01
Phil Terpolilli IRC
 Investor Relations Contact - -
Adel Mekhail SAM
 Sales & Marketing 63 01/19/01
Mary Fritz LAW
 General Counsel - 01/18/01
William P'Pool LAW
 General Counsel 58 01/16/01

Members of the board

Members of the board TitleAgeSince
Sheila Hopkins BRD
 Director/Board Member 68 01/15/01
Celeste Clark BRD
 Director/Board Member 71 02/21/02
Ted Virtue BRD
 Director/Board Member 63 -
Dawn Zier BRD
 Director/Board Member 59 01/20/01
James D'Arecca BRD
 Director/Board Member 53 01/23/01
Nat Ricciardi BRD
 Director/Board Member 75 26/16/26
John Byom BRD
 Director/Board Member 70 01/06/01
Ronald Lombardi CEO
 Chief Executive Officer 60 06/10/06

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 55,329,288 49,050,124 ( 88.65 %) 5,680,000 ( 10.27 %) 88.65 %

Shareholders

NameEquities%Valuation
BlackRock Advisors LLC
17.51 %
8,691,918 17.51 % 631 M $
Vanguard Fiduciary Trust Co.
11.59 %
5,756,138 11.59 % 418 M $
Dimensional Fund Advisors LP
6.917 %
3,434,466 6.917 % 249 M $
Macquarie Investment Management Business Trust
6.169 %
3,062,622 6.169 % 222 M $
Ariel Investments LLC
5.148 %
2,555,777 5.148 % 185 M $
STATE STREET CORPORATION
4.033 %
2,002,485 4.033 % 145 M $
Invesco Advisers, Inc.
2.320 %
1,151,694 2.320 % 84 M $
Geode Capital Management LLC
2.317 %
1,150,540 2.317 % 83 M $
Westwood Management Corp. (Texas)
2.266 %
1,124,914 2.266 % 82 M $
Allspring Global Investments LLC
2.110 %
1,047,352 2.110 % 76 M $

Company contact information

Prestige Consumer Healthcare, Inc.

660 White Plains Road Suite 250

10591, Tarrytown

+

http://www.prestigebrands.com
address Prestige Consumer Healthcare Inc.(PBH)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Prestige Consumer Healthcare Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
70.47 USD
Average target price
74.33 USD
Spread / Average Target
+5.48%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
PRESTIGE CONSUMER HEALTHCARE INC. Stock Prestige Consumer Healthcare Inc.
+15.11% 3.5B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. PBH Stock
  4. Company Prestige Consumer Healthcare Inc.